Kevin E. Lofton - May 5, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Amy Kim by Power of Attorney for Kevin E. Lofton
Stock symbol
GILD
Transactions as of
May 5, 2022
Transactions value $
$0
Form type
4
Date filed
5/6/2022, 06:52 PM
Previous filing
May 3, 2022
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Award $0 +2.44K +2.64% $0.00 95.2K May 5, 2022 By Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +15.9K $0.00 15.9K May 5, 2022 Common Stock 15.9K $61.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2.444 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 5, 2022.
F2 Includes 65,874 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022.